These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Immunosuppressive treatment of skin diseases. II. Clinical use of immunosuppressive drugs]. Ruszczak Z Przegl Dermatol; 1974; 61(4):529-35. PubMed ID: 4603603 [No Abstract] [Full Text] [Related]
24. [Immunosuppressive agents in dermatology]. Schuppli R Dtsch Med Wochenschr; 1970 Dec; 95(51):2576-7. PubMed ID: 5513651 [No Abstract] [Full Text] [Related]
25. Azathioprine in dermatology: a survey of current practice in the U.K. Tan BB; Lear JT; Gawkrodger DJ; English JS Br J Dermatol; 1997 Mar; 136(3):351-5. PubMed ID: 9115914 [TBL] [Abstract][Full Text] [Related]
26. Psoriasis and bullous pemphigoid treated with azathioprine. Primka EJ; Camisa C J Am Acad Dermatol; 1998 Jul; 39(1):121-3. PubMed ID: 9674409 [No Abstract] [Full Text] [Related]
34. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris. Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113 [TBL] [Abstract][Full Text] [Related]
35. Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid. Gürcan HM; Ahmed AR Br J Dermatol; 2009 Oct; 161(4):723-31. PubMed ID: 19548961 [TBL] [Abstract][Full Text] [Related]
36. Azathioprine. Ahmed AR; Moy R Int J Dermatol; 1981 Sep; 20(7):461-7. PubMed ID: 7026466 [No Abstract] [Full Text] [Related]
37. Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate. Wang TS; Tsai TF Acta Derm Venereol; 2014 Jan; 94(1):108-9. PubMed ID: 23624752 [No Abstract] [Full Text] [Related]
38. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases. Daoud YJ; Amin KG Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922 [TBL] [Abstract][Full Text] [Related]